Modulators of Multidrug Resistance Proteins in the Management of Anticancer and Antimicrobial Drug Resistance and the Treatment of Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|10|17|1732-1756

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.17, 2010-12, pp. : 1732-1756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment

By  

Current Medicinal Chemistry, Vol. 13, Iss. 16, 2006-07 ,pp. : 1859-1876

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Multidrug Resistance Modulators

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 4, 2004-01 ,pp. : 419-444

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

By Krishna R.   Mayer L.D.  

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 4, 2000-10 ,pp. : 265-283

Elsevier

Access to resources Recommend Favorite

Multi-drug resistance and cancer

By Atalay Can  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

The Antiepileptic Drug Topiramate is a Substrate for Human P-glycoprotein but Not Multidrug Resistance Proteins

By Luna-Tortós Carlos   Rambeck Bernhard   Jürgens Uwe   Löscher Wolfgang  

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2464-2470

Springer Publishing Company

Access to resources Recommend Favorite